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ABSTRACT 
Objective: The objective of the following study was a synthesis of nanocrystalline tetragonal zirconia (ZrO2) using simple sol–gel method and 
evaluation of its structural and biological properties.  
Methods: The sample was characterized by X-ray powder diffraction (XRD), Field Emission Scanning Electron Microscopy (FESEM), Transmission 
Electron Microscopy (TEM) and evaluated for cell growth study using 3T3 mouse fibroblast cells and for degradation using Phosphate Buffered 
Saline (PBS) solution. The synthesized materials were also evaluated for their antibacterial activity against Escherichia coli (E. coli) and 
Staphylococcus aureus (S. aureus) bacterial strains.  
Results: The XRD pattern shows that the tetragonal phase of nanocrystalline zirconia was obtained at relatively low temperature i.e. 300 °C. The 
FESEM images showed that the prepared sample consists of particles in the range of 35-69 nm and homogenous particle size distribution. The TEM 
images confirmed the results shown by FESEM images. The sample of zirconia has excellent tissue biocompatibility, higher cell growth and does not 
show the toxicity towards normal 3T3 mouse fibroblast cells. The result of qualitative antibacterial tests revealed that the nanocrystalline zirconia 
had an important inhibitory activity on E. coli and S. aureus. The sample shows stability at the physiological condition and does not show 
degradation.  
Conclusion: Nanocrystalline tetragonal zirconia shows higher cell growth and efficient antibacterial activity against E. coli and S. aureus bacterial 
pathogen and also it is stable at the physiological condition. Hence, it can be used for various biomedical applications. 
Keywords: Nanocrystalline zirconia, Sol-gel route, Antimicrobial action, Biomedical application 
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INTRODUCTION 
Zirconia ceramics has been increasingly used as implant 
biomaterials [1-3]. The excellent electrical, mechanical, optical and 
thermal properties of zirconia, makes it a good choice for application 
such as: structural materials [4], dental crowns [5], femoral heads 
for total hip replacement [6], solid oxide fuel cell electrolytes [7], air-
fuel ratio sensors for automotive applications [8], Catalytic 
application [9]. Pure zirconia exhibits three polymorphs of 
monoclinic, tetragonal and cubic symmetries. The monoclinic phase 
is stable at room temperature and transforms to the tetragonal 
phase at 1170 °C during heating while this phase transforms to the 
cubic one at 2370 °C [10, 11]. Zirconia and yttria stabilized zirconia 
(YTZP) are very attractive material for orthopedic applications. It 
has excellent biocompatibility, high fracture toughness; high 
strength and low wear rates. But they have some limitation such as 
fatigue failure and case studies show that delayed failure can occur 
in vivo due to crack propagation [12].  
To overcome these limitations, nanocrystalline materials are 
expected to show improved mechanical properties, and the 
nanometric features in the surface of prostheses seem to reduce the 
risk of rejection and enhance the proliferation of osteoblasts (bone-
forming cells) [13, 14]. It is well known that nanostructured 
materials exhibited unique physiochemical properties that are 
unseen in conventional bulk materials. Nano-ZrO2 exhibits much 
better chemical and physical properties as compared to normal ZrO2 
powder, due to the small particle diameter which will result in 
better sintering ability [15, 16]. The nanocrystalline tetragonal 
zirconia has not only high strength and fracture toughness but also a 
long-term biocompatibility. This makes it of major benefit for use in 
prosthetic hip, knee bearings and as superior dental material for 
crown and bridges [7]. Addressing the above issues, researchers 
have focused on developing the nanocrystalline structure of 
tetragonal zirconia for better performance. In recent years, 
inorganic antimicrobial agents are increased widely for control of 
microorganisms in various areas especially in the textile field [17-
19]. The key advantages of inorganic antimicrobial agents are 
improved safety and stability compared with organic antimicrobial 
agents [20]. The growing importance of biomaterials that prevent 
microbial growth is leading to the development of new biomaterials 
exhibiting antibacterial action, which create a bacteria-free 
environment while healing and repairing the defect area [21]. In the 
field of biomedical, many failures in the implantation are may be due 
to the formation of microbes in the implanted site. If the implant 
material has the capability of antimicrobial activity within them, 
then the problem of failure may be reduced. Moreover, microbes 
which cause a wide variety of infections in humans can be controlled 
by the antimicrobial materials [22]. 
There are many synthesis routes have been employed to obtain 
nano-sized tetragonal zirconia particles likes co-precipitation [23], 
Glycothermal Processing [24] Solid-State Reaction [25], Pechini 
Method [26], microwave-assisted sol-gel synthesis [27], bio-phase 
protocol [28], hydrothermal method [29] and sol-gel [30] 
processing. Among this Sol–gel is one of the best methods for 
synthesizing the nanoceramics e. g. zirconia, titania, hafnia, etc. 
Crystallite phase, crystallite size and other properties of zirconia 
nanoparticles are dependent on diverse parameters such as the type 
of precursor, pH during hydrolysis and thermal treatment [31]. In 
sol–gel route, purity, homogeneity, and physical properties of 
zirconia are manageable at a low temperature [14, 32-34].  
The present paper, however, proposes Hydroxypropyl methyl-
cellulose as organic additives. Also, the suggested additives are non-
toxic, easily available to store at a low temperature, adequately 
supplied and water-soluble. The sol–gel method is environmentally 
friendly and only takes 15–20 h in total are two considerable 
advantages. Organic additives make particles of spherical shape; 
reach the fairly uniform size and a decrease in the crystallite size 
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(35-69 nm) with the pure tetragonal phase of zirconia. We report 
the antimicrobial study of zirconia against E. coli and S. aureus 
bacterial pathogens.  
MATERIALS AND METHODS 
Sol-gel synthesis 
The entire precursor was taken of AR grade (99.99% pure) procured 
from SD fine scientific which included Zirconium n-propoxide, n-
propanol, Hydroxypropyl methyl cellulose, and ammonia. The ZrO2 
nanomaterial was synthesized using the method described by 
Heshmatpour et al. [4] with some modifications. Initially, n-propanol 
was added to Zirconium n-propoxide (70 wt %). Then resulting 
solution was hydrolysed using drop by drop addition of ammonia 
and distilled water with a pH value of 9 to 10. Hydroxypropyl methyl 
cellulose (3 g) was added to the solution under vigorous stirring. 
After homogenization, the solution was stirred at room temperature 
for an hour, so the resulting gel was polymerized. The gel was dried 
in an oven at a temperature of 100 °C for 12 h and sintered by 
using microwave furnace at 300 °C for 2 h. The resulting powders 
were then compacted into the mold and made pellets with the help 
of die and punch in a hydraulic dry press at a load of 4 Ton for 10 
min with a diameter of 10 mm and thickness of 2 mm. Each pellet 
consists of 0.25 g powder without any binder added and given the 
name P1, P2, and P3. The flow chart of Sol-gel synthesized zirconia 
as shown in fig 1. 
 
 
Fig. 1: Flow chart of ZrO2 synthesized by Sol-Gel method 
 
Evaluation of cell growth 
Cell culture 
The growth of cells in the presence of zirconia powder pellets was 
evaluated using 3T3 mouse fibroblast cell line which is obtained 
from National Center for cell Science, Pune. 3T3 cells were cultured 
in DMEM (Gibco, USA) containing 10% FBS and 1% antibiotics and 
antimycotic solution (Himedia, Mumbai) in CO2 incubator (37 °C, 5% 
CO2). DMEM was replaced every two days. When 3T3 cells reached 
80% confluence, they were trypsinized and counted using a 
hemocytometer. A density of 2.5 ×105 cells/well was seeded on each 
pellet in 24-well plates for cell counting, morphology and cell 
cytotoxicity tests for day 1 to 6.  
Evaluation of cell growth 
The zirconia powder pellets were sterilized by autoclaving at 120 °C 
and immersed in culture medium and cell growth was evaluated by 
cell counting on day 1 to 6. 3T3 cells in Dulbecco modified Eagles 
medium (DMEM) were seeded in 24 well plates as described above 
and were cultured in presence of pellets at 37 °C in 5% CO2 
atmosphere for day 1 to 6 so that cells were grown near pellets. At 
the end of incubation, the pellets were removed. The cells were 
washed with PBS and trypsinized using 0.25 % trypsin in PBS. The 
growth of cells was determined by counting cells using heamo-
cytometer and morphology of cells near pellets was observed with 
an inverted phase contrast microscope (Magnus). 
Inhibition of biofilm formation by zirconia nanomaterial 
The synthesized zirconia nanoparticles were evaluated for inhibition 
of biofilm formation against both Gram positive and Gram negative 
bacterial strains such as S. aureus (ATCC 33591) (Gram positive) and 
E. coli (ATCC 14948) (Gram negative) was obtained from Microbial 
Biotechnology Laboratory, Department of Biotechnology, Sant Gadge 
Baba Amravati University, Amravati.  
Bacterial inoculums were prepared by subculturing microorganisms 
into Hilton Muller agar (HMA) slants at 37 °C for 18 h. The zirconia 
nanoparticles were added in nutrient broth, and starting stock 
solution was of 20000 μg/ml concentration. The quantitative assay 
of the antimicrobial activity against microbial strains was performed 
using the liquid medium microdilution method, in 96-multiwell 
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plates, in order to establish the minimal inhibitory concentration 
(MIC). For this purpose, two-fold serial dilutions of the zirconia 
material ranging between 2000 to 1.95 μg/ml were performed in a 
200-μl volume of broth, and each well was seeded with 50 μl of 
microbial inoculum. Sterility control (wells containing only culture 
medium) and culture controls (wells containing culture medium 
seeded with the microbial inoculum) were used. The plates were 
incubated for 24 h at 37 °C [35-38]. At the end of the incubation 
period, the plastic wells were emptied, washed three times with 
Phosphate-buffered saline, fixed with cold methanol, and stained 
with 1% violet crystal solution for 30 min. The biofilm that formed 
on plastic wells was resuspended in 30% acetic acid. The intensity of 
the colored suspensions was assessed by measuring the absorbance 
at 490 nm. The last concentration of the zirconia nanomaterials that 
inhibited the development of microbial biofilm on the plastic wells 
was considered the minimum inhibitory concentration of biofilm 
development and was also expressed in micrograms per milliliter 
[39, 40]. 
Study of degradation 
Degradation test of Zirconia pellets was done by taking Phosphate 
Buffered Saline solution. The pH of the solution was 7.4 at 37 °C. 
Initially, took the weight of pellets P1, P2 and P3. Then pellets were 
soaked in phosphate buffered saline solution. The pellets were dried 
at 120oC after every one week, and final weight of the sample was 
taken. This process was repeated for five weeks.  
%𝑊𝑊𝑊𝑊𝑊𝑊𝑊𝑊ℎ𝑡𝑡 𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙 = 𝑊𝑊𝑙𝑙−𝑊𝑊𝑡𝑡
𝑊𝑊𝑙𝑙
∗ 100 … … … Eq. 1 
Where, Wo = initial weight of pellet 
Wt = final weight of pellet after soaking in phosphate buffered saline 
solution 
RESULTS AND DISCUSSION 
Powder X-ray Diffraction analysis of sintered samples was carried 
out in order to study the structural properties of zirconia using a 
rigaku diffractometer (XRD, miniflex rigaku), and then analyzed, 
using Ni-filtered CuKα radiation (λ = 0.1542 nm) in the step 
scanning mode, with tube voltage of 40 kV and tube current of 40 
mA. The XRD patterns were recorded in the 2θ range of 20 to 70 °, 
with a step size of 0.02 ° and step duration of 1 s. Field effect 
scanning electron microscopy (FESEM) technique was also used to 
observe the surface morphology. For this, a very small amount of 
powder was placed on a carbon adhesive tape, coated with 
gold/palladium and then observed in a FE-SEM (HITACHI S-4800). 
The sample was tested for transmission on Philips CM 200 TEM 
machine operated at a voltage of 200 kV and having a resolution of 
0.23 nm. 
XRD analysis 
The structural properties are studied by X-Ray diffraction technique. 
The XRD pattern of ZrO2 as shown in fig. 1(a), which is well matched 
with standard ICCD file no, 01-079-1764 of ZrO2 as shown in fig. 
1(b). Tetragonal phase formation starts by the loss of OH ions [41]. 
Tyagi et al. reported that transformation of amorphous Zr (OH)4 gel 
to a metastable tetragonal phase occurs at about 400 °C [31] and 
Heshmatpour et al. obtained zirconia in both phases that is 
monoclinic and tetragonal at 500 °-700 °C. Using sol–gel method, 
Suciu et al. made use of sucrose and pectin to synthesize YSZ 
nanoparticles [41, 42]. They used zirconium chloride (ZrCl4) and 
zirconium nitrate (Zr (NO3)4) to synthesize the nanopowder of YSZ. 
Their materials were mainly in cubic phase. Heshmatpour et al. 
made a use of glucose and fructose as organic additives to synthesize 
zirconia nanoparticles. They obtained zirconia in both phases that 
are monoclinic and tetragonal [3]. Through the presented organic 
additives in this paper, the sample that was calcined at low 
temperature that is 300 °C showed relatively high crystallinity with 
small particle size as observed by the intensity of the characteristic 
peaks of the tetragonal phase. The diffraction peaks in zirconia 
crystal structure, as shown in fig. 2(a), viz., (101), (110), (200), 
(211), (212), are matched well with the peaks shown in fig. 2(b) and 
Structural parameters of phase were estimated in table 1. 
  
Table 1: Structural parameters of Zirconia 
Phase Space group Crystal   Lateral parameters and angles 
 a/α b/β c/γ 
t-ZrO2 P42/nmc Tetragonal 3.596/90 °C 3.596/90 °C 5.184/90 °C 
 
Crystallite size of the ZrO2 was calculated by well-known Scherrer 
formula [43-45]. 
 
D = Kλ/βcosΘ ..……… Eq. 2 
 
Where K=0.9 is the shape factor, λ is the X-ray wavelength of Cu Kα 
radiation (0.1542 nm), Θ is the Bragg angle, and β is the full-width at 
half-maximum (FWHM) of the respective diffraction peak (in unit of 




Fig. 2: (a) XRD patterns of ZrO2 sintered at 300 °C and (b) 
standard ICDD file of ZrO2 
FESEM analysis 
Field Effect scanning Electron Microscope (FESEM) is well known 
and reliable technique to analyze nanoscale samples. It gives surface 
morphology of samples. The FESEM image of ZrO2 fig. 3(a-c) at 
different magnification shows a uniform distribution of particles and 
spherical like morphology. The image 3(a) shows the particles in the 
range of 35-69 nm. The formation and composition of crystalline of 
ZrO2 nanoparticles are confirmed from EDX analysis, fig. 3 (d) which 
reveals that the Zr and O as the only elements in the sample, high 
purity and no any other impurity in the sample. 
TEM analysis 
Transmission Electron Microscopy micrograph, as shown in fig. 4 (a-
b), confirm the shape of particles as that of FESEM image of fig 3(a-
c), with average particles size 5.84 nm which is good agreement with 
the one calculated by Scherrer formula. The selected area electron 
diffraction (SAED) pattern in fig. 4 (c) shows the concentric rings of 
crysatalline planes. 
Cells growth assessment OF ZrO2 
Cells growth and morphological characterization for ZrO2 pellets 
were studied. The fig.5 shows cells growth in the presence of 
nanocrystalline ZrO2 pellets along with control (in the absence of 
pellets). The growth of cells was measured using hemocytometer for 
day 1 to 6. This shows that the growth of cells along with pellets of 
ZrO2 is similar to that of control. It means that nanocrystalline ZrO2 
powder does not show any sign of cytotoxicity. fig 6(a-c) shows 
images of 3T3 fibroblast cells near ZrO2 pellets which show that after 
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2 d the growth of cells was found in control as well as in the 
presence of nanocrystalline ZrO2 pellets. After 6 d the cell growth 
was found to be higher as compared to 2 d which indicates that 
nanocrystalline ZrO2 pellets did not cause any toxic effect on cells. 
Fig. 6 shows a regular pattern of cell growth of fibroblast cells which 
is characteristic of a test conducted on ZrO2 pellets. The in vitro 
study conducted on cytotoxicity of ZrO2 shows very high 
biocompatibility of materials produced. Nanocrystalline ZrO2 can be 
considered as non-toxic. Also, the numbers of living cells near the 
ZrO2 pellets were found to be increased as compared to controls (fig. 
6). The present data reveals the no signs of cytotoxicity and the rate 
of cell growth was higher in the case of nanocrystalline ZrO2 pellets. 
 
 
Fig. 3: FE-SEM images of (a-c) ZrO2 at different magnification, (d) EDAX spectrum of ZrO2 
 
 
Fig. 4: (a-b) TEM images of ZrO2 (c) selected area electron diffraction pattern (SAED) of ZrO2 
(d)
Thakare et al. 








Fig. 6: (a-d) optical microscope images of a culture of mouse 
fibroblasts after 2 d and 6 d contact with the ZrO2 pellet, (M) 
area of pellet 
 
Inhibition of biofilm formation by zirconia nanomaterial  
Gram-positive S. aureus and Gram-negative E. coli were widely used 
for bacterial experiments. S. aureus and E. coli live on the body 
surface of mammals and sometimes occur infection to them [46]. 
Therefore, S. aureus and E. coli strains were selected for this 
antibacterial study. Fig. 7 shows the decrease in the population 
growth of E. coil and S. aureus with an increase in the concentration 
of zirconia nanoparticles. The growth of bacteria in the absence of 
zirconia nanoparticles (control) was considered as 100 % and the 
concentration required to inhibit the formation of biofilm due to the 
growth of bacteria to 50% was calculated. The inhibitory 
concentration that inhibited the development of microbial biofilm of 
S. aureus and E. coli was found to be 15.62 μg/ml and 7.81 μg/ml 
respectively and considered as the minimum inhibitory 
concentration. The antimicrobial performance of ZrO2 nanoparticles 
due to the following assumptions: active oxygen species generated 
from the ZrO2 nanoparticles actively inhibit the growth of S. aureus 
cells by accumulation or deposition on the surface of S. aureus cells. 
It is also suggested that ZrO2 nanoparticles are able to slow down E. 
coli growth due to disorganization of E. coli membranes, which 
increases membrane permeability leading to accumulation of 
nanoparticles in the bacterial membrane and cytoplasmic regions of 
the cells. From the above discussion we clearly came to know about 
the enhanced antimicrobial activity of ZrO2 nanoparticles [28]. In 
dentistry, restoration failure is generally attributed to a combination 
of oral bacteria and inappropriate features of dental materials. 
Efficient dental restorative materials are important for an adequate 
recovery of masticatory and esthetic functions. However, these 
materials are prone to biofilm formation, affecting oral health [47]. 
So, ZrO2 nanomaterial inhibiting biofilm formation can be used in 
biomedical especially in dentistry applications. 
 
 
Fig. 7: Effect of ZrO2 powder on the bacterial growth (E. coli and 
S. aureus) 
Data is represented as mean±SEM (n=3) 
 
Degradation of ZrO2 
Fig. 8 shows that degradation of ZrO2 nanomaterials was 0.0021% 
for five weeks which is very negligible. It means that a zirconia 
nanomaterial does not show any degradation and stable at 
physiological condition in PBS solution.  
 
 
Fig. 8: degradation of ZrO2 pellets in PBS 
Data is represented as mean±SEM (n=3) 
 
CONCLUSION 
In this study, our aim was to synthesize nanocrystalline zirconia by 
using the simple sol-gel method with organic additive and to study 
its antibacterial property. The formation of the tetragonal crystalline 
phase of ZrO2 was confirmed by powder XRD analysis at relatively 
low temperature using microwave furnace. The morphology, 
particle size, and nanostructure were analyzed using FESEM. TEM 
data also confirmed the formation of the nanostructure. TEM 
micrograph and SAED pattern confirmed the crystalline perfection 
in the prepared zirconia nanoparticles. Nanocrystalline zirconia 
does not inhibit cell growth of normal 3T3 mouse fibroblast cells 
which indicated its nontoxic nature. The zirconia nanoparticles 
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showed the significant antibacterial activity against E. coli and S. 
aureus bacterial pathogen and also it is stable at the physiological 
condition. Hence, it can be used for various biomedical applications. 
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